Nevada Attorney General Aaron Ford urged consumers on October 6, 2026 to check eligibility for compensation for certain generic drug purchases and file a claim online. He said that in late September the U.S. District Court for the District of Connecticut granted preliminary approval of a plan, filed by Nevada and a coalition of 47 other states and territories, to distribute settlement money paid by generic drug manufacturers.
The settlements, with Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage’s parent Emcure, total about $96.5 million. They resolve claims that the companies illegally conspired to raise generic drug prices.
The states’ antitrust litigation began in 2016. The first complaint named Heritage, 17 other corporate defendants, two individuals and 15 generic drugs. A 2019 complaint named Teva and 21 other manufacturers and 16 executives. A third complaint, to be tried first, covers 80 topical generic drugs and names 26 corporate and 10 individual defendants. The states filed a fourth complaint earlier this year naming Novartis AG, Sandoz Group AG and Sandoz AG.